ACTACORE Trademark

Trademark Overview

On Wednesday, April 5, 2023, a trademark application was filed for ACTACORE with the United States Patent and Trademark Office. The USPTO has given the ACTACORE trademark a serial number of 97873721. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, October 10, 2024. This trademark is owned by Ferring B.V.. The ACTACORE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating orthopedic diseases and conditions
actacore

General Information

Serial Number97873721
Word MarkACTACORE
Filing DateWednesday, April 5, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, October 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating orthopedic diseases and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 1, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFerring B.V.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHoofddorp 2132 JX
NL

Trademark Events

Event DateEvent Description
Saturday, April 8, 2023NEW APPLICATION ENTERED
Monday, May 1, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 2, 2024ASSIGNED TO EXAMINER
Tuesday, January 2, 2024NON-FINAL ACTION WRITTEN
Tuesday, January 2, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 26, 2024FINAL REFUSAL WRITTEN
Tuesday, March 26, 2024FINAL REFUSAL E-MAILED
Tuesday, March 26, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, May 28, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, May 28, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, July 1, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, October 10, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, October 10, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, July 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 1, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, July 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

actacore diseases conditions orthopedic treating preparations pharmaceutical